What is functional dyspepsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Functional Dyspepsia?

Functional dyspepsia (FD) is a symptom-based disorder characterized by bothersome epigastric pain or burning, postprandial fullness, or early satiation in the absence of any structural, organic, systemic, or metabolic disease that could explain these symptoms. 1

Core Definition and Diagnostic Requirements

FD requires investigation (typically endoscopy) to exclude organic causes before diagnosis can be made. Approximately 80% of people with dyspepsia will ultimately be diagnosed with FD following endoscopy. 1

Cardinal Symptoms

The disorder includes one or more of the following:

  • Epigastric pain or burning (discomfort in the upper central abdomen)
  • Postprandial fullness (feeling abnormally full after eating)
  • Early satiation (feeling full during a meal, preventing completion of a regular-sized meal)

Additional symptoms may include belching, nausea, or upper abdominal bloating, but heartburn alone is not considered dyspepsia, although it can coexist. Persistent vomiting is atypical and should prompt consideration of another disorder. 1

Clinical Subtypes

FD is classified into two distinct subtypes based on symptom patterns 1:

Epigastric Pain Syndrome (EPS)

  • Epigastric pain or burning occurring at least 1 day per week
  • Pain may occur regardless of meals (can be induced by meals, relieved by meals, or occur while fasting)
  • Symptoms severe enough to impact usual activities

Postprandial Distress Syndrome (PDS)

  • Postprandial fullness and/or early satiation occurring at least 3 days per week
  • Symptoms primarily triggered by meals
  • Severe enough to impact usual activities or prevent finishing regular-sized meals

Important caveat: Patients frequently have overlapping features of both EPS and PDS, particularly in secondary and tertiary care settings. 1

Diagnostic Criteria Evolution

Rome IV Criteria (Research Standard)

  • Symptoms present for the last 3 months
  • Symptom onset at least 6 months before diagnosis
  • No structural disease on endoscopy

Clinical Criteria (Practical Use)

The Rome Foundation has acknowledged that the strict 6-month requirement limits applicability in routine practice and potentially delays treatment. For clinical practice, symptoms need only be present for 8 weeks, with all other criteria unchanged. 1 This modification addresses the concern that overly restrictive criteria demonstrated much lower prevalence rates and delayed diagnosis.

Epidemiology and Prevalence

FD affects approximately 7% of the population using Rome IV criteria, though this varies by country (2.4% in Japan to 12.3% in Egypt). Using broader definitions, dyspepsia prevalence approaches 30%. 1 The disorder is more common in females and associated with smoking, NSAID use, and H. pylori infection. 1

Pathophysiology Context

While not purely a definition issue, understanding that FD represents a disorder of gut-brain interaction is crucial. The condition involves problems with two-way communication between the upper gastrointestinal tract and the brain, including altered nerve sensitivity, delayed gastric emptying in some patients, duodenal mucosal inflammation, and psychological factors. 1 Normal test results do not mean there is no cause—the pathophysiology is simply not detectable by standard structural investigations.

Key Distinction from Gastroparesis

FD and gastroparesis are symptom-based constructs with significant overlapping features that cannot be fully distinguished by symptoms or gastric emptying studies alone. The preferred terminology is "FD with or without delayed gastric emptying" rather than separating these as distinct entities. 1

References

Related Questions

How can I differentiate gastritis, functional dyspepsia, and acid peptic disease and what are the first‑line treatment options?
What are the classifications of dyspepsia?
How should I evaluate and manage a patient with functional dyspepsia who experiences constant hunger?
How do I distinguish functional dyspepsia from gallbladder disease and manage each condition?
How should I manage a patient with a 20-year history of functional dyspepsia refractory to multiple treatments, now referred to a gastroenterologist?
What is the appropriate management of a chylothorax associated with malignancy?
Can methotrexate cause bone marrow bleeding?
How can shivering be treated in a patient undergoing active cooling (targeted temperature management)?
What is the appropriate management of gastrointestinal bleeding in a patient with end-stage renal disease?
How should I manage a patient who took methotrexate daily for a week and is on dabigatran (Pradaxa), who developed severe thrombocytopenia (platelet count 19 ×10⁹/L) after receiving folinic acid (leucovorin) rescue, with platelet recovery only after stopping the anticoagulant?
What is the optimal proton pump inhibitor and dosing regimen for an ESRD patient with acute gastrointestinal bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.